A Prospective muLticEnter Registry in chrONic coronARy synDrOme

Not yet recruitingOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions

Coronary Artery Disease

Interventions

DRUG

Antiplatelet Agents

Antiplatelet agents more commonly used at time of percutaneous coronary intervention in patients with chronic coronary syndrome

All Listed Sponsors

lead

University of Roma La Sapienza

OTHER

NCT06198673 - A Prospective muLticEnter Registry in chrONic coronARy synDrOme | Biotech Hunter | Biotech Hunter